Article
Randomized placebo-controlled trial of perindopril in normotensive, normoalbuminuric patients with type 1 diabetes mellitus.
QJM : monthly journal of the Association of Physicians - 1 Feb 2001
Kvetny J, Gregersen G, Pedersen R S
Abstract excerpt
Diabetic nephropathy is one of the leading causes of end-stage renal disease. We examined whether ACE inhibitor treatment may have a nephroprotective effect in normotensive insulin-dependent diabetic patients without microalbuminuria and with normal glomerular filtration rate (GFR), and whether any effect was associated with the ACE genotype. In a prospective double-blind randomized study, normotensive patients...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
